Loading
Biomarkers / Alzheimer Disease / Alzheimer’s Disease · Journal article
Neurobiology of Aging · May 9, 2026
Early or partial results. Treat as a signal, not a conclusion.
This cross-sectional network analysis maps associations between blood inflammatory markers and demographic/CSF biomarkers of aging and Alzheimer's pathology in cognitively unimpaired adults. Multiple inflammation networks (CXCL5-driven, IL-6/FGF-21-driven, IFN-gamma/CXCL9-driven, and others) showed associations with age, sex, and CSF Aβ42/Aβ40, but plasma Aβ42/Aβ40 was not significantly associated with any network. The work illustrates the complexity of interpreting blood-based immune markers but does not establish causation or clinical utility.
Cross-sectional observational network analysis. Cognitively unimpaired aging adults; specific eligibility criteria and recruitment setting not stated in abstract.. Intervention: None; observational study of blood inflammatory marker networks..
CXCL5-driven blood inflammation network associated with age, sex, and CSF Aβ42/Aβ40 IL-6- and FGF-21-driven network associated with sex, CSF Aβ42/Aβ40, and Qalb (CSF-serum albumin ratio) IFN-gamma- and CXCL9-driven network associated with age and CSF Aβ42/Aβ40
No clinical outcomes (cognition, dementia conversion, mortality) examined; utility for clinical decision-making unclear
This network analysis suggests that blood inflammation markers associate with Alzheimer's CSF biomarkers and demographic factors in complex, pleiotropic patterns, but the lack of effect sizes, clinical endpoints, and cross-sectional design limits immediate application to clinical assessment or intervention. The non-association of plasma Aβ42/Aβ40 with inflammatory networks contrasts with CSF associations and underscores challenges in blood-based biomarker interpretation.
Observational network analysis identifying associations between blood inflammation markers and aging/AD biomarkers, but without causal inference, comparator group, or effect sizes to support clinical decision-making.
As stated by the source record.
Quoted from the source exactly as published.
This network analysis suggests that blood inflammation markers associate with Alzheimer's CSF biomarkers and demographic factors in complex, pleiotropic patterns, but the lack of effect sizes, clinical endpoints, and cross-sectional design limits immediate application to clinical assessment or intervention. The non-association of plasma Aβ42/Aβ40 with inflammatory networks contrasts with CSF associations and underscores challenges in blood-based biomarker interpretation.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Blood inflammatory marker studies in aging and Alzheimer's disease (AD) research have faced numerous interpretative and methodological challenges that have hindered the field's understanding of the relationship between immune network regulation/dysregulation and aging health factors. We examined how blood inflammation markers directly relate to each other in typical aging, cognitively unimpaired adults using a conditional network analytic modeling approach. We further evaluated how blood inflammation networks relate to key aging risk factors by decomposing the networks into eigenvectors with associated hub proteins and then evaluated the associations of the resulting eigenproteins with demographic information, core biomarkers of AD pathobiology in CSF and blood, and immune health history. Networks of blood inflammation markers showed both divergent and convergent relationships with outcomes, including strong associations between a CXCL5-driven blood inflammation network and age, sex, and CSF Aβ42/Aβ40, and an IL-6- and FGF-21-driven network and sex, CSF Aβ42/Aβ40, and Qalb (CSF-serum albumin ratio). An IFN-gamma- and CXCL9-driven network was associated with both age and CSF Aβ42/Aβ40, whereas blood inflammation networks with hub proteins of CXCL11/CXCL9 and CCL19/CCL4, respectively, were associated solely with sex. Finally, an MCP-3-, MCP-4-, and CXCL6-driven network was associated with cumulative surgical procedure exposures. Despite associations between CSF Aβ42/Aβ40 and multiple networks, plasma Aβ42/Aβ40 was not significantly associated with any blood inflammatory network. Our findings highlight the importance and the challenges of inferring immune pathophysiology from blood-based markers; mirroring the complex pleiotropic biology of inflammation, blood inflammatory markers show associations with multiple demographic and salient health factors in aging adults.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.